Delivery Order SPE2DB20D3103-SPE2DB23FM4B8
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,024.85 and is for the supply of VEMLIDY 25 MG TABLET UU 30S, a type of medication. The contract type is Firm Fixed Price and the ultimate completion date is December 18, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET UU 30S. The contract has a ceiling value of $10,386.12 and is a firm fixed-price delivery order, with a completion date of September 4, 2024. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,980.81, is for the supply of VEMLIDY 25 MG TABLET medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,057.22, is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price and is designated as a delivery order, with an ultimate completion date of March 25, 2025. This contract is not associated with a set-aside program. AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,744.10 firm fixed price contract is for the supply of the pharmaceutical product VEMLIDY 25 MG TABLET in 30-tablet units. The order has an ultimate completion date of August 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to procure a...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,111.68 firm fixed-price contract is for the supply of VEMLIDY 25 MG TABLET, a prescription medication, with an ultimate completion date of August 28, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VEMLIDY 25 MG TABLET in units of 30s, with a ceiling value of $2,370.92 and a period of performance through May 19, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,319.46, is for the supply of VEMLIDY 25 MG TABLET UU 30S, a prescription medication. The delivery order contract is a firm fixed-price instrument with a completion date of June 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $2,693.01 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 27, 2024. The order is for the supply of VEMLIDY 25 MG TABLET, a prescription medication, to support DLA's mission to provide medical commodities to military treatment facilities and other government healthcare providers. The contract has an ultimate completion date of August 28, 2024 and does not utilize a small...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VEMLIDY 25 MG TABLET, a prescription medication, with a ceiling value of $3,917.80 and a performance period through July 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM4B8Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4559879496 units of VEMLIDY 25 MG TABLET, a medication used in the treatment of certain medical conditions. The contract has a ceiling value of $5,055.60 and an ultimate completion date of February 9, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract award does not mention any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 2/8/23 |